Efficacy and safety of elobixibat in hemodialysis patients with chronic constipation: a retrospective study
Abstract Background Hemodialysis patients are likely to develop constipation as a complication due to food and fluid restrictions. Elobixibat is a new laxative that inhibits the ileal bile acid transporter expressed in the terminal ileum, suppresses bile acid reabsorption, increases the amount of bi...
Main Authors: | Takefumi Shono, Hiroyuki Hyakutake |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-04-01
|
Series: | Renal Replacement Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s41100-020-00267-y |
Similar Items
-
Uncontrolled, Open-Label Pre-Dinner Administration of Elobixibat in Japanese Adults with Chronic Constipation: A Retrospective Chart Review
by: Takeo Odaka, MD, PhD, et al.
Published: (2020-01-01) -
Elobixibat alleviates chronic constipation in hemodialysis patients: a questionnaire-based study
by: Daigo Kamei, et al.
Published: (2020-01-01) -
Efficacy and Safety of Elobixibat in Elderly Patients with Chronic Constipation: A Single-center, Observational Study
by: Tatsuya Abe, et al.
Published: (2020-07-01) -
Impact of salt taste dysfunction on interdialytic weight gain for hemodialysis patients; a cross-sectional study
by: Mai Tanaka, et al.
Published: (2019-04-01) -
The Efficacy and Safety of Elobixibat for the Elderly with Chronic Constipation: A Multicenter Retrospective Cohort Study
by: Dohi, O., et al.
Published: (2020)